Solventum Third-Quarter Sales Fall 7.0% to $1.949 Billion; Adjusted EPS of $1.45 as Full-Year Adjusted EPS Guidance Is Raised to $7.20–$7.30
EAGAN, Minnesota — Solventum (NYSE: SOLV) reported on November 5 its financial results for the third quarter ended September 30, 2026. According to the company's official earnings release, net sales were $1,949 million, down 7.0% on a reported basis and down 2.8% on an organic basis; the release said the organic decline reflects the expected 630 basis point impact of the reversal of $125 million in second-quarter advance orders placed ahead of the planned ERP system cutover during the quarter.
The company reported a net loss of $12 million, compared with net income of $1,266 million a year earlier, and GAAP diluted earnings per share of $(0.07), compared with $7.22 a year earlier, a period the release said included the gain on sale of the purification and filtration business. Adjusted diluted earnings per share were $1.45, down 3.6%. Operating cash flow was $177 million and free cash flow was $97 million. Adjusted operating income margin was 19.9%, compared with 20.6% a year earlier.
By segment, MedSurg sales were $1,211 million, comprising Advanced Wound Care of $528 million and Infection Prevention and Surgical Solutions of $683 million; Dental Solutions sales were $317 million, down 6.7% on a reported basis and 7.4% organically; and Health Information Systems sales were $356 million, up 3.3% on a reported basis and 4.4% organically. The release also disclosed FDA 510(k) clearance for the combined use of Restrata and V.A.C. Therapy.
For the full year, the company expects organic sales growth toward the high end of the +2.5% to +3.0% range, raised its adjusted EPS guidance to $7.20 to $7.30 from $7.10 to $7.20, and affirmed free cash flow guidance of $200 million to $300 million. Solventum said its ERP system cutovers are complete, it has exited approximately 90% of 3M transition service agreements, and its separation from 3M is more than 90% complete. Chief Executive Officer Bryan Hanson said in the release that third-quarter results were ahead of the company's expectations, with every segment contributing.
—-
Source: Solventum Corporation
Published by GSM · USA (original Chinese edition)
Photo: 医院病房内的医疗设备（示意）。（图／Wikimedia Commons，CC BY-SA 4.0）| Medical equipment in a hospital ward (illustrative). (Photo: Wikimedia Commons, CC BY-SA 4.0)
In Oklahoma City, Oklahoma, the Oklahoma Insurance Department (OID) announced on November 3 that Commissioner Glen Mulready has approved a 4.8% decrease in workers' compensation insurance loss costs f2026-11-09
Logistics Group CTP Reaches $500 Million Deal to Expand in Vietnam as Clients Seek China Alternative2026-11-09